16-28487524-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS1_Supporting

The NM_001042432.2(CLN3):​c.392G>A​(p.Ser131Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S131G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 0 hom. )

Consequence

CLN3
NM_001042432.2 missense

Scores

2
11
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:9

Conservation

PhyloP100: 3.13

Publications

5 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.30586666).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.00033 (482/1461780) while in subpopulation NFE AF = 0.000409 (455/1111946). AF 95% confidence interval is 0.000378. There are 0 homozygotes in GnomAdExome4. There are 239 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042432.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
NM_001042432.2
MANE Select
c.392G>Ap.Ser131Asn
missense
Exon 7 of 16NP_001035897.1Q13286-1
CLN3
NM_000086.2
c.392G>Ap.Ser131Asn
missense
Exon 6 of 15NP_000077.1Q13286-1
CLN3
NM_001286104.2
c.320G>Ap.Ser107Asn
missense
Exon 6 of 15NP_001273033.1Q13286-7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
ENST00000636147.2
TSL:1 MANE Select
c.392G>Ap.Ser131Asn
missense
Exon 7 of 16ENSP00000490105.1Q13286-1
CLN3
ENST00000359984.12
TSL:1
c.392G>Ap.Ser131Asn
missense
Exon 6 of 15ENSP00000353073.9Q13286-1
CLN3
ENST00000565316.6
TSL:1
c.392G>Ap.Ser131Asn
missense
Exon 6 of 14ENSP00000456117.1Q13286-3

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152020
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000259
AC:
65
AN:
251154
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000493
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000330
AC:
482
AN:
1461780
Hom.:
0
Cov.:
31
AF XY:
0.000329
AC XY:
239
AN XY:
727182
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000112
AC:
5
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.0000937
AC:
5
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000409
AC:
455
AN:
1111946
Other (OTH)
AF:
0.000265
AC:
16
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
24
47
71
94
118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
152020
Hom.:
0
Cov.:
32
AF XY:
0.000189
AC XY:
14
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.0000966
AC:
4
AN:
41402
American (AMR)
AF:
0.000131
AC:
2
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68004
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000426
Hom.:
0
Bravo
AF:
0.000268
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000683
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000296
AC:
36
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Neuronal ceroid lipofuscinosis 3 (3)
-
1
-
CLN3-related disorder (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
Neuronal ceroid lipofuscinosis (1)
-
1
-
Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (1)
-
1
-
not provided (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.70
D
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.93
D
M_CAP
Pathogenic
0.47
D
MetaRNN
Benign
0.31
T
MetaSVM
Uncertain
0.77
D
MutationAssessor
Uncertain
2.0
M
PhyloP100
3.1
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.20
Sift
Uncertain
0.012
D
Sift4G
Uncertain
0.0070
D
Polyphen
0.74
P
Vest4
0.57
MVP
0.92
MPC
0.49
ClinPred
0.13
T
GERP RS
5.5
Varity_R
0.51
gMVP
0.59
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144770450; hg19: chr16-28498845; API